Announcing new Book release:

The public narrative has been flattened into a “red meat allergy” soundbite, while real alpha gal behaves like a systemic, high-stakes condition with triggers that extend beyond obvious food. Biting Back explains the full exposure map, the real patterns, and why so many patients remain sick even when they “did everything right.”

The obsession with delayed allergic reactions has become a convenient buzzword that makes the condition sound mysterious, while excusing poor education and lazy case analysis. Biting Back breaks down what delayed really means, why timing varies, and how to stop being manipulated by a narrative that replaces solutions with trivia.

No, and believing otherwise has harmed patients for years. Biting Back explains why the food allergy test (IgE) is only a screening tool, not a severity meter, not a progress tracker, and not a reliable predictor of real-world reactions. The book teaches what these numbers can and cannot tell you, and why a “better number” can still leave you reacting.

Avoidance is not treatment. Avoidance is surrender dressed up as a plan. Biting Back exposes the rhetorical trick of calling restriction a “treatment.” It explains why symptom management after a reaction is not a treatment for the condition at all. The book explains what a corrective strategy actually means when your goal is recovery rather than lifelong fear. Plus, Biting Back explains why substances related to mammal meat are virtually impossible to avoid—no matter how hard you try. Biting Back explains why the public was trained to accept avoidance as treatment, and what real treatment for the condition actually means. 

Alpha gal is not a cookbook problem. Mammal-derived substances are embedded throughout modern life, including in foods, medications, supplements, and everyday products. Most patients are never warned about that reality, so they “avoid meat” and still react. Biting Back explains the exposure map in documented detail, including why people keep getting blindsided, what to look for, and how to stop living as a full-time ingredient detective. 

The biggest lie is that nothing can be done. The second biggest lie is that avoidance is “the treatment.” Biting Back documents how those lies persist, who benefits from the misdirection, and why the existence of a corrective option has been ignored or minimized.

SAAT stands for Soliman Auricular Allergy Treatment. It was developed by Nader Soliman, MD, based on the scientific developments of neurologist Paul Nogier, MD (1908–1996). Dr. Donald Liebell began applying SAAT clinically to alpha gal allergy in 2013 and later published the first research documenting successful outcomes (2020).  SAAT matters because it is a corrective approach, rather than an avoidance-only strategy. Biting Back explains the neurological logic, the clinical process, and why SAAT stands apart from the standard pattern of labeling, shrugging, and prescribing fear.

No. SAAT is not a medication and it is not a “lifetime injection solution.” Biting Back explains why this matters, why procedure-based care is treated differently than pharmaceuticals, and why patients should not confuse the absence of a pill with the absence of a real treatment. SAAT is designed to reduce allergic reactivity through neurological self-regulation, rather than managing symptoms after the fact. 

No, and anyone promising that is not advising you correctly or responsibly. Biting Back explains how recovery is approached with intelligent planning, cautious reintroduction, and safety-first strategy, including why premature testing can psychologically and physically backfire.